{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:10:53Z","timestamp":1794535853567,"version":"4.9.1"},"reference-count":115,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Development and Technology"],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.1080\/10837450.2025.2584127","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:36:25Z","timestamp":1762346185000},"page":"1389-1412","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["The functional attributes of co-processed excipients in direct compression"],"prefix":"10.1080","volume":"30","author":[{"given":"Renate","family":"Coetzee","sequence":"first","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University","place":["Potchefstroom, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josias","family":"Hamman","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University","place":["Potchefstroom, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Steenekamp","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University","place":["Potchefstroom, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannlie","family":"Hamman","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University","place":["Potchefstroom, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"e_1_3_3_2_1","volume-title":"Ansel\u2019s pharmaceutical dosage forms and drug delivery systems","author":"Allen LV","year":"2014","unstructured":"Allen LV, Ansel HC. 2014. Ansel\u2019s pharmaceutical dosage forms and drug delivery systems. (10th ed.). Philadelphia, Pennsylvania (USA): Lippincott Williams & Wilkins.","edition":"10"},{"key":"e_1_3_3_3_1","first-page":"1","volume-title":"Innovative dosage forms: design and development at early stage","author":"Alsirawan MHD","year":"2020","unstructured":"Alsirawan MHD, Paradkar A. 2020. Impact of the polymorphic form of drugs\/NCEs on preformulation and formulation development. In: Bachhav YG, editor. Innovative dosage forms: design and development at early stage. Hoboken, New Jersey (USA): Wiley. p. 1\u201347."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/pr9020267"},{"key":"e_1_3_3_5_1","first-page":"801","article-title":"Investigation of novel multifunctional co-processed excipient for direct compression","volume":"31","author":"Ambore SM","year":"2014","unstructured":"Ambore SM, Tekale J, Gattani SG. 2014. Investigation of novel multifunctional co-processed excipient for direct compression. World Appl Sci J. 31:801\u2013810. https:\/\/www.idosi.org\/wasj\/wasj31(5)14\/19.pdf","journal-title":"World Appl Sci J"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19904"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.5920\/bjpharm.2017.08"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450701831294"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.2478\/v10007-010-0016-9"},{"key":"e_1_3_3_10_1","unstructured":"BASF. [date unknown]. Ludipress\u00ae and Ludipress\u00ae LCE \u2013 The quickest route to direct tableting. Jun 11]. accessed 2025. [https:\/\/download.basf.com\/p1\/EN_StaticDocuments_5719\/en\/Ludipress%C2%AE_Ludipress%C2%AE_LCE_-_One-step_tabletting"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2020.10.027"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2016.07.008"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103316"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.30574\/gscbps.2023.23.1.0100"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijpps.2019v11i1.29265"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450500464255"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21886"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2025.02.004"},{"issue":"6","key":"e_1_3_3_19_1","first-page":"24","article-title":"Development of Coprocessed Excipients","volume":"46","author":"Challener CA.","year":"2022","unstructured":"Challener CA. 2022. Development of Coprocessed Excipients. Pharm Technol Eur. 46(6):24\u201326, 49 [accessed 2025 Oct 5]. https:\/\/www.pharmtech.com\/view\/development-of-coprocessed-excipients.","journal-title":"Pharm Technol Eur"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-008-9088-y"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-019-09372-w"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41120-023-00088-3"},{"issue":"4","key":"e_1_3_3_23_1","first-page":"1480","article-title":"A review: co-processed excipients \u2013 An alternative to novel chemical entities","volume":"1","author":"Chaudhari PD","year":"2012","unstructured":"Chaudhari PD, Phatak AA, Desai U. 2012. A review: co-processed excipients \u2013 An alternative to novel chemical entities. Int J Pharm Chem Sci. 1(4):1480\u20131498.","journal-title":"Int J Pharm Chem Sci"},{"key":"e_1_3_3_24_1","unstructured":"Colorcon. 2019. StarCap\u00ae \u2013 Superior flow maize starch. [accessed 2025 Jun 10]. https:\/\/20823278.fs1.hubspotusercontent-na1.net\/hubfs\/20823278\/PDFs%20Pharma%20downloads\/Colorcon_Starcap_Brochure_2019.pdf"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-013-0036-0"},{"key":"e_1_3_3_26_1","unstructured":"Daicel. 2019a. Co-processed excipient for direct compression: designed for orally disintegrating tablets \u2013 HiSORAD\u2122 HSR-D03. [accessed 2025 Jun 12]. https:\/\/www.pharmaexcipients.com\/product\/hisorad-hsr-d03\/?attachment_id=134610&download_file=j4xe7zrz2uggj"},{"key":"e_1_3_3_27_1","unstructured":"Daicel. 2019b. Granfiller D\u2122 \u2013 Co-processed excipient for direct compression designed for orally disintegrating tablets. [accessed 2025 Jun 12]. https:\/\/www.pharmaexcipients.com\/wp-content\/uploads\/2020\/04\/WP1_GRANFILLER-D-for-Direct-Compression-Designed-for-ODTs.pdf"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-010-9523-8"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103907"},{"key":"e_1_3_3_30_1","unstructured":"Deorkar N Farina J Miinea L Randive S. 2008. Directly compressible high functionality granular microcrystalline cellulose based excipient manufacturing process and use thereof. [accessed 2025 Mar 1]. https:\/\/patentimages.storage.googleapis.com\/df\/26\/d4\/928bbf026418f1\/SG185257A1.pdf"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.02.005"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.04.001"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-018-1104-2"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijpi.20251862"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0939-6411(01)00184-9"},{"key":"e_1_3_3_36_1","unstructured":"FDA (US). 1995. Guidance for industry: immediate release solid oral dosage forms\u2014Scale-up and postapproval changes: chemistry manufacturing and controls in vitro dissolution testing and in vivo bioequivalence documentation. Center for Drug Evaluation and Research. [accessed 2025 Oct 7]. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/supac-ir-immediate-release-solid-oral-dosage-forms-scale-and-post-approval-changes-chemistry"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244646"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.36290\/csf.2018.025"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.2174\/187221113804805847"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-973x.167692"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1081\/pdt-120018487"},{"issue":"1","key":"e_1_3_3_42_1","first-page":"76","article-title":"A review of co-processed directly compressible excipients","volume":"8","author":"Gohel MC","year":"2005","unstructured":"Gohel MC, Jogani PD. 2005. A review of co-processed directly compressible excipients. J Pharm Pharm Sci. 8(1):76\u201393. [accessed 2025 Feb 5https:\/\/sites.ualberta.ca\/\u223ccsps\/JPPS8(1)\/P.Jogani\/excipients.pdf","journal-title":"J Pharm Pharm Sci"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1208\/pt0801009"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2013.861479"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apt.2008.09.004"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-020-00055-9"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1208\/ps060216"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.08.007"},{"key":"e_1_3_3_49_1","unstructured":"[IPEC] International Pharmaceutical Excipient Council Europe. 2017. Co-processed excipient guide for pharmaceutical excipients. [accessed 2024 Jul 8]. https:\/\/www.gmp-compliance.org\/files\/guidemgr\/20171030_Co-processed_Excipient_Guide(FINAL_FOR_PUBLICATION).pdf"},{"key":"e_1_3_3_50_1","unstructured":"[IPEC. International Pharmaceutical Excipient Council Europe. 2023.] Glossary. [accessed 2024 Jul 15]. https:\/\/www.ipec-europe.org\/glossary\/c.html"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/adv.21582"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.38467"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.4155\/ppa-2022-0036"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13071022"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0939-6411(01)00186-2"},{"key":"e_1_3_3_56_1","unstructured":"JRS Pharma. 2018. PROSOLV\u00ae SMCC\u2014Silicified microcrystalline cellulose. [accessed 2025 Feb 18]. https:\/\/www.jrspharma.com\/pharma-wAssets\/docs\/brochures\/br-prosolv-smcc-1809.pdf"},{"key":"e_1_3_3_57_1","unstructured":"JRS Pharma. accessed 2025. PROSOLV\u00ae EASYtab brochure. [accessed Oct 10]. https:\/\/www.pharmaexcipients.com\/product\/prosolv-easytab-sp-lm\/?attachment_id=190820&download_file=rfve7956ei1rz"},{"key":"e_1_3_3_58_1","unstructured":"JRS Pharma. 2025. The performance of PROSOLV\u00ae EASYtab SP in Four Medium-Dose Direct Compression Formulations with Morphologically Challenged Model APIs. [https:\/\/www.jrspharma.com\/pharma-wAssets\/docs\/technical-information\/ti_prosolv_easytab-sp.pdf"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.2174\/1872211314999210104211125"},{"key":"e_1_3_3_60_1","unstructured":"Kerry. 2016. LubriTose\u2122 Self lubricating excipients \u2013 Shifting paradigms in tablet manufacturing. [accessed 2025 Jun 11]. https:\/\/www.pharmaexcipients.com\/product\/lubritose-sd\/?attachment_id=149060&download_file=zf16d314iwy29"},{"issue":"10","key":"e_1_3_3_61_1","article-title":"Novel excipients: a rare species","volume":"23","author":"Kolter K.","year":"2011","unstructured":"Kolter K. 2011. Novel excipients: a rare species. Pharm Technol Eur. 23(10)[accessed 2025 Jun 12]. https:\/\/www.pharmtech.com\/view\/novel-excipients-rare-species.","journal-title":"Pharm Technol Eur"},{"issue":"5","key":"e_1_3_3_62_1","first-page":"423","article-title":"Development and evaluation of melt-in-mouth tablets of metoclopramide hydrochloride using novel co-processed superdisintegrants","volume":"76","author":"Ladola MK","year":"2014","unstructured":"Ladola MK, Gangurde AB. 2014. Development and evaluation of melt-in-mouth tablets of metoclopramide hydrochloride using novel co-processed superdisintegrants. Indian J Pharm Sci. 76(5):423\u2013429. accessed 2025 Jun 11]. https:\/\/www.ijpsonline.com\/articles\/development-and-evaluation-of-meltinmouth-tablets-of-metoclopramide-hydrochloride-using-novel-coprocessed-superdisintegr.pdf.","journal-title":"Indian J Pharm Sci"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1016364613722"},{"key":"e_1_3_3_64_1","unstructured":"Li JX Carlin B Ruszkay T. 2008. Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations. [accessed 2025 Feb 15]. https:\/\/patentimages.storage.googleapis.com\/1c\/4b\/f2\/0bdaf7d25afcce\/WO2008057267A2.pdf"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0939-6411(01)00162-X"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.06.023"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-014-0163-y"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2129-z"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122165"},{"key":"e_1_3_3_70_1","unstructured":"Meggle. 2023. Technical brochures. [accessed 2025 Jun 12]. https:\/\/www.meggle-excipients.com\/products"},{"key":"e_1_3_3_71_1","unstructured":"Menon A Gillece T Chakrabarti S. 1996. Co-processing method for making a free-flowing compressible powder and tablet therefrom. US Patent 560927A. [accessed 2024 Jul 11]. https:\/\/patents.google.com\/patent\/US5560927A\/en"},{"key":"e_1_3_3_72_1","unstructured":"Merck. 2019. Parteck\u00ae ODT Excipient. [accessed 2025 Jun 11]. https:\/\/www.sigmaaldrich.com\/deepweb\/assets\/sigmaaldrich\/product\/documents\/404\/990\/parteck-odt-brochure-ad4688en-ms.pdf"},{"key":"e_1_3_3_73_1","unstructured":"Merlin. 2025. What is strain rate sensitivity. [accessed 2025 Mar 3]. https:\/\/www.merlin-pc.com\/faqs\/strain-rate-sensitivity?.com"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.21474\/IJAR01\/14637"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.3(6).1580-92"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639040601050197"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2015.1131717"},{"issue":"1","key":"e_1_3_3_78_1","first-page":"52","article-title":"Co-processed excipients for solid dosage forms","volume":"28","author":"Nachaegari SK","year":"2004","unstructured":"Nachaegari SK, Bansal AK. 2004. Co-processed excipients for solid dosage forms. Pharm Technol. 28(1):52\u201365. accessed 2025 Jun 12]. https:\/\/cdn.sanity.io\/files\/0vv8moc6\/pharmtech\/44c8205eb6835e795c5075e5b8ad23e8b4b8f7b0.pdf\/article-81434.pdf","journal-title":"Pharm Technol"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2016.10.039"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-1483.100021"},{"key":"e_1_3_3_81_1","unstructured":"Pabst W Gregorov\u00e1 E. 2007. Characterization of particles and particle systems. Institute of Chemical Technology Prague. [accessed 2025 May 10]. https:\/\/old.vscht.cz\/sil\/keramika\/Characterization_of_particles\/CPPS%20_English%20version_.pdf"},{"key":"e_1_3_3_82_1","unstructured":"Panda B Raoot A Kilor V Sapkal N. 2011. Co-processed excipients: An overview of formulation aspects physical characteristics and role as a pharmaceutical aid. Pharmatutor. [accessed 2025 Mar 5]. https:\/\/www.pharmatutor.org\/articles\/overview-of-co-processed-pharmaceutical-excipients-formulation-aspects?.com"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.17485\/ijst\/2009\/v2i10.3"},{"issue":"1","key":"e_1_3_3_84_1","first-page":"125","article-title":"Development of directly compressible co-processed excipient for dispersible tablets using 32 full factorial design","volume":"1","author":"Patel SS","year":"2009","unstructured":"Patel SS, Patel NM. 2009. Development of directly compressible co-processed excipient for dispersible tablets using 32 full factorial design. Int J Pharm Pharm Sci. 1(1):125\u2013148. [accessed 2025 Jun 12https:\/\/innovareacademics.in\/journal\/ijpps\/Vol%201%20Issue%201\/125.pdf","journal-title":"Int J Pharm Pharm Sci"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02749-2"},{"key":"e_1_3_3_86_1","unstructured":"Paul S. 2002. Ingredient technology: SMCC leads the way. Manufacturing Chemist. [accessed 2025 Feb 7]. https:\/\/www.manufacturingchemist.com\/ingredient-technology-smcc-leads-the-way\u201331112"},{"issue":"1","key":"e_1_3_3_87_1","first-page":"14","article-title":"Review on novel pharmaceutical co-processed excipients","volume":"2","author":"Pawar SB","year":"2019","unstructured":"Pawar SB, Ahirrao SP, Kshirsagar SJ. 2019. Review on novel pharmaceutical co-processed excipients. Pharm Reson. 2(1):14\u201320 [accessed 2025 Jun 12]. https:\/\/www.pharmaexcipients.com\/wp-content\/uploads\/2019\/11\/Review-on-novel-pharmaceutical-co-processed-excipients.pdf.","journal-title":"Pharm Reson"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-973x.133059"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-20206-8_13"},{"issue":"4","key":"e_1_3_3_90_1","first-page":"1322","article-title":"Preparation, characterization and evaluation of a new co-processed excipient as directly compressible vehicle in tablet formulation","volume":"4","author":"Ramja K","year":"2013","unstructured":"Ramja K, Chowdary KPR. 2013. Preparation, characterization and evaluation of a new co-processed excipient as directly compressible vehicle in tablet formulation. J Glob Trends Pharm Sci. 4(4):1322\u20131328. [accessed 2025 Jun 10https:\/\/www.jgtps.com\/admin\/uploads\/EjgX75.pdf","journal-title":"J Glob Trends Pharm Sci"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-021-02071-1"},{"key":"e_1_3_3_92_1","unstructured":"Rao VU Balasubramania J Haldar RK. 2012. Co-processed excipient compositions. US Patent 20120178822A1. [accessed 2025 Mar 5]. https:\/\/patentimages.storage.googleapis.com\/8a\/99\/fe\/54d83ee902158f\/US20120178822A1.pdf"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1773-2247(06)50087-5"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2011.645833"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.06.013"},{"key":"e_1_3_3_96_1","unstructured":"Roquette. 2020. Customizing appealing dosage forms. [accessed 2025 Jun 12]. https:\/\/www.roquette.com\/-\/media\/roquette-sharepoint-libraries\/marcomonline\u2013-pharma\/roquette-pharma-nutraceutical-otc-brochure-pearlitol-sw-f.pdf"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2018.1483386"},{"key":"e_1_3_3_98_1","volume-title":"Handbook of pharmaceutical excipients","author":"Rowe RC","year":"2009","unstructured":"Rowe RC, Sheskey PJ, Quinn ME. 2009. Handbook of pharmaceutical excipients. 6th ed. Pharmaceutical Press.","edition":"6"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v14i8.6747"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.25258\/ijddt.13.3.13"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639049409042687"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.15171\/bi.2015.04"},{"key":"e_1_3_3_103_1","unstructured":"SPI Pharma. 2019a. Advantose\u2122 FS95 \u2013 Directly compressible fructose. [accessed 2025 Jun 10]. https:\/\/www.spipharma.com\/media\/3295\/advantose-fs95-sell-sheet-d5-final.pdf"},{"key":"e_1_3_3_104_1","unstructured":"SPI Pharma. 2019b. Compressol\u00ae SM \u2013 Co-processed polyol. [accessed 2025 Jun 11]. https:\/\/www.spipharma.com\/media\/3306\/compressol-sell-sheet-final.pdf"},{"key":"e_1_3_3_105_1","unstructured":"SPI Pharma. 2019c. Pharmaburst\u2122 500 \u2013 Orally disintegrating tablet platform. [accessed 2025 Jun 10]. https:\/\/www.spipharma.com\/media\/3307\/pharmaburst-sell-sheet-final.pdf"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2009.04.008"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2011.633506"},{"key":"e_1_3_3_108_1","unstructured":"Thomas Processing. 2025. Common problems in tablet manufacturing. [accessed 2025 Mar 5]. https:\/\/thomasprocessing.com\/common-problems-in-tablet-manufacturing\/"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.06.055"},{"key":"e_1_3_3_110_1","unstructured":"Thoorens G Leclercq B Ruszkay T. 2010. Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients. US Patent 20110104288A1[accessed 2025 Feb 10]. https:\/\/patentimages.storage.googleapis.com\/83\/67\/d2\/2dd27c25664c11\/US20110104288A1.pdf"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1773-2247(12)50097-3"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00081"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780429320057-11-13"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2022.05.001"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00031"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2739428"}],"container-title":["Pharmaceutical Development and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10837450.2025.2584127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T15:52:48Z","timestamp":1764345168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10837450.2025.2584127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11,26]]}},"alternative-id":["10.1080\/10837450.2025.2584127"],"URL":"https:\/\/doi.org\/10.1080\/10837450.2025.2584127","relation":{},"ISSN":["1083-7450","1097-9867"],"issn-type":[{"value":"1083-7450","type":"print"},{"value":"1097-9867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}